In addition to these findings, the study on genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA provided insights into non-invasive tumor classification, which could enhance patient stratification and monitoring (ref: Maire doi.org/10.1093/neuonc/). The integration of molecular profiling in neurosurgical outcomes is becoming increasingly vital, as it allows for tailored therapeutic approaches that can significantly impact survival rates and quality of life. Overall, these studies underscore the evolving landscape of neurosurgical interventions, where the combination of innovative techniques and molecular insights is paving the way for improved patient outcomes.